Cancer Survival in England, cancers diagnosed 2015 to 2019, followed up to 2020

For adults diagnosed with cancer between 2015 and 2019, followed up to the end of 2020, age-standardised estimates of 1-year and 5-year net survival by cancer group are presented in Figure 1 for males and Figure 2 for females, ordered by 1-year net survival estimates.

1. Survival estimates were age-standardised using a standard set of age-specific weights provided by the International Cancer Survival Standard (ICSS).
2. Survival estimates presented are for all persons except for cervix, ovary, uterus and vulva (females only) and larynx, prostate and testis (males only).
3. 5-year estimates are not presented for, breast in males or Hodgkin lymphoma, stomach, mesothelioma and bladder for females.
4. The International Classification of Diseases 10th Revision (ICD-10) was used to classify cancer sites.

Figures 1 and 2 were ordered by 1-year net survival. They show the pattern of cancers from high to low 5-year net survival estimates are not always the same as for 1-year net survival, or between males and females. Melanoma of the skin had the highest survival estimate of all cancers for both 1-year and 5-year survival, for both males and females. For melanoma of the skin, the 1-year survival estimate for males was 97.6% and for females was 98.8%, and the 5-year net survival estimates for males and females were 89.9% and 94.8% respectively. Pancreatic cancer had the lowest survival estimate of all cancers for 1-year, for both males (26.4%) and females (27.4%). For 5-year survival, pancreatic survival was lowest for females (7.8%), but mesothelioma was lowest for males (6.3%).

For males, 5-year survival was below 20% for mesothelioma, oesophagus, liver, lung, brain and pancreatic cancers. For females, 5-year survival was below 20% for liver, oesophagus, brain and pancreatic cancers.